近日,云顶新耀发布公告称,公司与Hasten Biopharmaceuticals (Asia) Limited签署了一份意向书,涉及可能收购目标公司Hasten Biopharmaceuticals (SG) Pte. Ltd.的全部股权。根据意向书,云顶新耀将在签署后五个营业日内向卖方支付可退还定金2亿元。该定金将用于可能的收购或按双方协议退还。此次收购旨在增强公司在亚太地区的业务规模,目标...
Source Link近日,云顶新耀发布公告称,公司与Hasten Biopharmaceuticals (Asia) Limited签署了一份意向书,涉及可能收购目标公司Hasten Biopharmaceuticals (SG) Pte. Ltd.的全部股权。根据意向书,云顶新耀将在签署后五个营业日内向卖方支付可退还定金2亿元。该定金将用于可能的收购或按双方协议退还。此次收购旨在增强公司在亚太地区的业务规模,目标...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.